BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khairy M, Abdel-Rahman M, El-Raziky M, El-Akel W, Zayed N, Khatab H, Esmat G. Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup. Hepat Mon 2012;12:e6718. [PMID: 23346149 DOI: 10.5812/hepatmon.6718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Liu C, Lin C, Wang P, Tseng T, Lin HH, Kao J. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association 2015;114:923-8. [DOI: 10.1016/j.jfma.2015.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
2 Alavian SM. Liver biopsy versus non-invasive tests in determining liver disease status. Iran J Radiol 2015;12:e17078. [PMID: 25793088 DOI: 10.5812/iranjradiol.17078] [Reference Citation Analysis]
3 Shousha HI, Saad Y, Saleh DA, Dabes H, Alserafy M, ElShazly Y, Said M. Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 2020;32:1017-22. [PMID: 31789947 DOI: 10.1097/MEG.0000000000001612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abd El-salam SM, Ezz MM, Hashem S, Elakel W, Salama R, Elmakhzangy H, Elhefnawi M. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients. Informatics in Medicine Unlocked 2019;17:100267. [DOI: 10.1016/j.imu.2019.100267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shehab H, Elbaz T, Deraz D, Hafez A, Elattar I. The efficacy of a Hansenula-derived 20 kDa pegylated interferon alpha-2a in the treatment of genotype 4 chronic hepatitis C. J Interferon Cytokine Res 2014;34:727-33. [PMID: 24730368 DOI: 10.1089/jir.2013.0127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Fouad R, Elsharkawy A, Abdel Alem S, El Kassas M, Alboraie M, Sweedy A, Afify S, Abdellatif Z, Khairy M, Esmat G. Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals. Eur J Gastroenterol Hepatol 2019;31:1129-34. [PMID: 30896550 DOI: 10.1097/MEG.0000000000001400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Behairy OG, El-shimi OS, Shalan NH. Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases. Egypt Pediatric Association Gaz 2021;69. [DOI: 10.1186/s43054-021-00072-0] [Reference Citation Analysis]
8 Saito M, Yano Y, Hirano H, Momose K, Yoshida M, Azuma T. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepat Mon 2015;15:e22978. [PMID: 25788955 DOI: 10.5812/hepatmon.22978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Said M, Soliman Z, Daebes H, M El-Nahaas S, El-Serafy M. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study. Expert Rev Gastroenterol Hepatol 2019;13:1189-95. [PMID: 31702417 DOI: 10.1080/17474124.2019.1690990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Sultana C, Erscoiu SM, Grancea C, Ceausu E, Ruta S. Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania. Hepat Mon 2013;13:e8611. [PMID: 23613686 DOI: 10.5812/hepatmon.8611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Cordie A, Salama A, El-Sharkawy M, El-Nahaas SM, Khairy M, Elsharkawy A, Hassany M, Esmat G. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C. J Med Virol 2018;90:1106-11. [PMID: 29476628 DOI: 10.1002/jmv.25064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
12 Khairy M, Fouad R, Mabrouk M, El-Akel W, Awad AB, Salama R, Elnegouly M, Shaker O. The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis. Hepat Mon 2013;13:e10509. [PMID: 24065997 DOI: 10.5812/hepatmon.10509] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat. 2015;22:245-253. [PMID: 25073725 DOI: 10.1111/jvh.12285] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
14 Huang C, Seah JJ, Tan CK, Kam JW, Tan J, Teo EK, Kwek A, Wong YJ, Tan M, Ang TL, Kumar R. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. Clin Res Hepatol Gastroenterol 2021;45:101528. [PMID: 33268036 DOI: 10.1016/j.clinre.2020.08.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhao Y, Thurairajah PH, Kumar R, Tan J, Teo EK, Hsiang JC. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore. Hepatobiliary Pancreat Dis Int 2019;18:143-8. [PMID: 30558838 DOI: 10.1016/j.hbpd.2018.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Hashem A, Awad A, Shousha H, Alakel W, Salama A, Awad T, Mabrouk M. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study. Arab J Gastroenterol 2021;22:88-92. [PMID: 33985905 DOI: 10.1016/j.ajg.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Abd-Elsalam SM, Ezz MM, Gamalel-Din S, Esmat G, Elakel W, ElHefnawi M. Derivation of "Egyptian varices prediction (EVP) index": A novel noninvasive index for diagnosing esophageal varices in HCV Patients. J Adv Res 2022;35:87-97. [PMID: 35024195 DOI: 10.1016/j.jare.2021.02.005] [Reference Citation Analysis]
18 Gamil M, Alboraie M, El-Sayed M, Elsharkawy A, Asem N, Elbaz T, Mohey M, Abbas B, Mehrez M, Esmat G. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients. J Med Virol 2018;90:1080-6. [PMID: 29315641 DOI: 10.1002/jmv.25026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
19 Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ 2014;5:3. [PMID: 24484532 DOI: 10.1186/2042-6410-5-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 12.3] [Reference Citation Analysis]